Atlas Trials

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Clinical trial NCT01648465 · TERMINATED

Trial details

NCT number
NCT01648465
Sponsor
Hellenic Cooperative Oncology Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine TumorsPancreatic Neuroendocrine Tumors
Start date
2012-08-06
Primary completion
2017-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.